Interferon regulatory factor 7 (IRF7) mRNA (IRF7 mRNA)

Interferon regulatory factor 7 (IRF7) mRNA is the transcript encoding the IRF7 protein, a lymphoid-specific transcription factor that serves as the master regulator of the type I interferon (IFN) response (Honda et al., 2005, Nature). It is primarily expressed in plasmacytoid dendritic cells and is essential for the robust production of IFN-alpha and IFN-beta following the activation of pattern recognition receptors like TLR7 and TLR9 (Colina et al., 2008, Nature). In the context of autoimmune diseases such as systemic lupus erythematosus (SLE), overactivation of the IRF7 pathway leads to a persistent interferon signature that drives chronic inflammation and tissue damage (Kirou et al., 2005, Arthritis & Rheumatism). Conversely, genetic deficiencies in IRF7 mRNA expression or function are associated with increased susceptibility to severe viral infections, including influenza and SARS-CoV-2 (Zhang et al., 2020, Science). Therapeutic strategies targeting IRF7 mRNA include the use of antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs) designed to reduce its translation in overactive states, as well as mRNA-based delivery systems to restore function in deficiency states.

Other names

IRF-7 mRNAInterferon regulatory factor 7 transcriptIRF7 transcript

Targeted degradation of the IRF7 transcript via antisense oligonucleotides or RNA interference to prevent the translation of the IRF7 protein, thereby inhibiting the type I interferon signaling pathway.